Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | SWIRM domain protein | 0.0006 | 0 | 0.5 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0014 | 0.0494 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0069 | 0.3809 | 1 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0014 | 0.0494 | 0.1295 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0014 | 0.0494 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0014 | 0.0494 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0014 | 0.0494 | 0.1295 |
Schistosoma mansoni | amine oxidase | 0.0014 | 0.0494 | 0.1295 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0069 | 0.3809 | 1 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0014 | 0.0494 | 0.5 |
Mycobacterium ulcerans | oxidoreductase | 0.0014 | 0.0494 | 0.5 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0014 | 0.0494 | 0.1295 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0494 | 0.0493 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.002 | 0.0846 | 0.0871 |
Brugia malayi | Myb-like DNA-binding domain containing protein | 0.0167 | 0.9706 | 1 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0069 | 0.3809 | 1 |
Echinococcus multilocularis | 0.0014 | 0.0494 | 0.1295 | |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0014 | 0.0494 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0014 | 0.0494 | 1 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0014 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.3809 | 0.3809 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.4161 | 0.4161 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0014 | 0.0494 | 0.5 |
Leishmania major | UDP-galactopyranose mutase | 0.0014 | 0.0494 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0014 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0846 | 0.0845 |
Brugia malayi | hypothetical protein | 0.0014 | 0.0494 | 0.0508 |
Mycobacterium ulcerans | dehydrogenase | 0.0014 | 0.0494 | 0.5 |
Entamoeba histolytica | SWIRM domain protein | 0.0006 | 0 | 0.5 |
Giardia lamblia | hypothetical protein | 0.0006 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0014 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0494 | 0.0493 |
Brugia malayi | SWIRM domain containing protein | 0.0075 | 0.4161 | 0.4287 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0014 | 0.0494 | 0.5 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0014 | 0.0494 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0014 | 0.0494 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0 | 0.5 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0014 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.9706 | 0.9706 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0014 | 0.0494 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0014 | 0.0494 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0014 | 0.0494 | 0.1295 |
Onchocerca volvulus | CoRest homolog | 0.0172 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0006 | 0 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0014 | 0.0494 | 0.5 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0014 | 0.0494 | 0.5 |
Mycobacterium ulcerans | monoamine oxidase | 0.0014 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.3809 | 0.3809 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = -23.22 % | Inhibition of STAT3 in IL-6-stimulated human HepG2 cells at 10 uM treated for 1 hr prior to IL-6 challenge measured after 5.5 hrs by luciferase reporter gene assay | ChEMBL. | 23376248 |
Inhibition (functional) | = 2.47 % | Cytotoxicity against human MDA-MB-468 cells harboring constitutively harboring activated STAT3 assessed as inhibition of cell viability at 10 uM after 72 hrs by MTT assay | ChEMBL. | 23376248 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.